logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10034877 B1

PDFFull Text
Date of Patent:
Jul. 31, 2018

Filed:

Oct. 06, 2016

Treatment for diabetes in patients inappropriate for metformin therapy

Applicant:

Boehringer Ingelheim International Gmbh, Ingelheim am Rhein, DE;

Inventors:

Klaus Dugi, London, GB;

Eva Ulrike Graefe-Mody, Ingelheim am Rhein, DE;

Ruth Harper, Reading, GB;

Hans-Juergen Woerle, Munich, DE;

Assignee:

Boehringer Ingelheim International GmbH, Ingelheim am Rhein, DE;

Attorneys:

Marc Began

David L. Kershner

Primary Examiner:

Marcela M Cordero Garcia

Int. Cl.
CPC ...
C07D 473/06 (2006.01); A61K 31/496 (2006.01); A61K 45/06 (2006.01); A61K 31/40 (2006.01); A61K 31/403 (2006.01); A61K 31/4025 (2006.01); A61K 31/422 (2006.01); A61K 31/427 (2006.01); A61K 31/4375 (2006.01); A61K 31/4439 (2006.01); A61K 31/4985 (2006.01); A61K 31/506 (2006.01); A61K 31/5025 (2006.01); A61K 31/513 (2006.01); A61K 31/522 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/496 (2013.01); A61K 9/0053 (2013.01); A61K 31/40 (2013.01); A61K 31/403 (2013.01); A61K 31/4025 (2013.01); A61K 31/422 (2013.01); A61K 31/427 (2013.01); A61K 31/4375 (2013.01); A61K 31/4439 (2013.01); A61K 31/4985 (2013.01); A61K 31/506 (2013.01); A61K 31/5025 (2013.01); A61K 31/513 (2013.01); A61K 31/522 (2013.01); A61K 45/06 (2013.01);
Abstract

The present invention relates to the finding that certain DPP-4 inhibitors are particularly suitable for treating and/or preventing metabolic diseases, particularly diabetes, in patients for whom metformin therapy is inappropriate due to intolerability or contraindication against metformin.

Find Patent Forward Citations

Dugi, Klaus. (2018). Treatment for diabetes in patients inappropriate for metformin therapy (U.S. Patent No. 10034877). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10034877

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…